Navigation Links
HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference

d components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or technologies that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Company's operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Company's ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. We currently have no commercial products intended to diagnose, treat, prevent or cure any disease. The statements contained in this press release regarding our on going research and development and the results attained by us to-date have not been evaluated by the Food and Drug Administration. There can be no assurance that further research and development, and /or whether clinical trial results, if any, will validate and support the results of our preliminary research and studies. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that HepaLife will be able to develop commercially viable products on the basis of its technologies. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-Q and Form 10-K filings with the Securities and Exchange Commission. These reports and filings may be inspected and copied at the Public Reference Room maintained by the U.S. Securities & Exchange Commission at 100 F Street, N.E., Washington, D.C. 20549. You can obtain information about operation of the Public Reference Room by calling the U.S. Securities & Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange Commission also maintains an Internet site that co
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
2. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
3. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
4. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
5. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
6. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
7. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
8. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
9. Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetixs AAGP
10. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
11. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
Post Your Comments:
(Date:7/7/2015)... Research and ... of the "Biomedical Photoacoustic Imaging Patent ... This patent landscape focuses on photoacoustic ... safe, non-invasive, non-ionizing imaging technique. The technique ... alternative to traditional medical imaging approaches. The ...
(Date:7/7/2015)... VIEJO, Calif. , July 7, 2015 /PRNewswire/ ... company focused on developing innovative devices for the ... R. Michael Kleine has joined its Board ... over 25 years of medical device and healthcare ... biomedical companies where he has commercialized numerous leading-edge ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... , CHAPEL HILL, N.C., Nov. 25 ... chief executive officer, will present at the Piper Jaffray 21st ... 2009, at The New York Palace Hotel in New York ... company,s two leading antibiotic clinical programs for the treatment of ...
... , FRAMINGHAM, Mass. and SYDNEY, Nov. 25 HeartWare International, ... and provider of less invasive, miniaturized circulatory support technologies revolutionizing ... is scheduled to make an investor presentation at the 21st ... on Wednesday, December 2, 2009. The conference is being held ...
Cached Medicine Technology:HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2
(Date:7/7/2015)... , ... July 07, 2015 , ... ... provide payment parity for an expanded list of telehealth services available to Medicare ... from Representatives Gregg Harper (R-MS 3), Diane Black (R-TN 6) and Peter Welch ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... a mark on the cosmetic surgery industry with its commitment, teamwork, and dedication ... VisitandCare.com partnered medical provider is committed to patient safety, world-class results, and compassionate ...
(Date:7/7/2015)... York, NY (PRWEB) , ... July 07, 2015 , ... ... thing that can help pass those long, stressful days at work is knowing that ... aren’t always as laid back and stress free as imagined. Planning for a vacation ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers for ... of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for a ... have sex with men (MSM) and transgender women, the groups at highest risk ...
(Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading audit, tax, ... give back to the community through company-wide volunteering efforts. , On an annual basis, ... day to assisting those in need throughout Baltimore and Washington D.C. , ...
Breaking Medicine News(10 mins):Health News:The American Telemedicine Association Supports Legislation to Expand Medicare Coverage for Telemedicine Services 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2
... international group of eating disorders say that the ... disorders is like blaming// parents for diabetes or ... statements by fashion model Gisele Bundchen stating that ... and further stigmatize eating disorders. ...
... than a dozen people have taken ill and have been ... ‘false’ and ‘ baseless’ by spokesman Xiong Yuanda of the ... was no infectious ‘unknown’ disease, doing the rounds in the ... the Health bureau has sought to dispel reports carried by ...
... AIDS Healthcare Foundation on Monday is expected to file ... pharmaceutical company Pfizer//. The decision is the outcome for ... Viagra in advertisements, Reuters reports. ,According to ... increased risky sexual behavior, as well as cases of ...
... Kochi: In its efforts to promote Kerala as an ideal destination ... shows in the US, Britain, Dubai, Muscat, Kuwait, Sri Lanka and ... because it has to be systematic and we have asked the ... of the policy and when we announce it shortly we would ...
... in the Sydney CBD is linked to the Royal Automobile ... However, they could not confirm the link. ,Seven ... belonging to the Legionella family, Legionella pneumophilia, have been reported ... the Circular Quay area on New Year's Eve. ...
... University and pediatric specialists at Baylor College of Medicine have ... as passkeys that allows drugs to enter cancer cells. ... of the journal Organic and Biomolecular Chemistry. ,All ... Cell walls, or membranes, form a protective cocoon around the ...
Cached Medicine News:Health News:'Families' - Doesn’t Cause Anorexia Nervos 2Health News:'Families' - Doesn’t Cause Anorexia Nervos 3Health News:AIDS Healthcare Foundation to File Lawsuit Against Pfizer 2Health News:Buckyballs Used as 'Passkey' into Cancer Cells 2
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Steroid eluting pacemaker leads...
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Medicine Products: